Researchers say around 70% of the US needs to get the coronavirus vaccine to stop the pandemic. But questions around the vaccines and regional differences add...
Study looks at treating severe COVID-19 with umbilical-cord derived mesenchymal stem cells Credit: University of Miami Health System University of Miami Miller School of Medicine researchers...
‘Like smart bomb technology to the lung,’ randomized trial shows Credit: © Dr. Camillo Ricordi Dr. Camilo Ricordi, director of the Diabetes Research Institute (DRI) and...
BioSpace reviewed the top 10 novel drug approvals of 2020, loosely based on projected earnings in the upcoming years.
In advance of public vaccination, a quick and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies, the molecules that aid in protection...
As Operation Warp Speed – the Trump administration’s program to develop and distribute a Covid-19 vaccine – struggles to ramp up vaccinations, one of the approaches under...
A new year, a new addition to the stock portfolio – what can make more sense than that? The right time to buy, of course, is...
Long-lasting symptoms appear unrelated to how bad your infection was, though women appear more affected than men.
Experts at India’s drugs regulator approved two coronavirus vaccines for emergency use: one developed by AstraZeneca/Oxford University, and the other backed by a state-run SIIPL institute.
2020 was a year to remember, for so many reasons, but there is one reason that might not be obvious: it was the year of the...
Russia Developing "Highly Efficient Antidote" To Fight COVID, Preclinical Tests Show 99% Effectiveness Russia is using its vaccine program for soft power diplomacy. On Tuesday, Argentina and Belarus...
The benefits of getting vaccinated far outweigh the risks – here's why you should get vaccinated against COVID-19 and other diseases.
The Covid-19 vaccine developed by British drugmaker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April 2021,...
China approved a Covid-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Dec. 31, the country's first approved shot for general public use...
Sinopharm announced that the Chinese biopharmaceutical company's Covid-19 vaccine candidate had an efficacy rate of 79% based on interim analysis of Phase III trials.
ER Nurse Tests Positive 8 Days After Being Vaccinated for COVID-19
The United States Department of Defense (DOD) awarded Moderna a contract valued at $1,966,598,000 for an additional 100 million doses of the company's Covid-19 vaccine.
A vaccine being developed by the Nanovaccine Institute at Iowa State University (ISU) will be able to be administered without needles and in one dose.
A resurgence of coronavirus cases in several countries and a new COVID-19 variant identified in the UK are boosting fears over a slew of lockdown and...
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, The post 5 ways digital health, and digital...
Insiders are an interesting lot. From an investor’s perspective, corporate officers have access to information – and information has always been the key to successful investing.
A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials.
Can you feel the ground moving beneath your feet? Shares of Ocugen (OCGN) skyrocketed over 800% in the past three trading sessions after the biopharmaceutical company...
Experimental monoclonal antibody not efficacious in Phase 3 trial Credit: NIAID Preliminary results of a phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody...
Credit: n/a December 22 – Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have...
These 2 Penny Stocks Are Poised for...
Now that two COVID vaccines have been authorized by the FDA, questions arise. Today, a physician from Indiana University School of Medicine answers five reader questions.
The trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp The post 2020 in review: COVID-19 and patient...
The first injections of Moderna's Covid-19 vaccine started to be administered on Dec. 21 after the U.S. Food and Drug Administration granted Emergency Use Authorization (EUA)...
Gov Newsom In Quarantine; 30+ Countries Bar Travel With UK Over COVID Mutation: Live Updates Summary: Number of countries banning travel from UK tops 30 Israe,...